These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 7504912
21. Single breath carbon monoxide transfer factor in different forms of chronic airflow obstruction in a general population sample. Knudson RJ, Kaltenborn WT, Burrows B. Thorax; 1990 Jul; 45(7):514-9. PubMed ID: 2396232 [Abstract] [Full Text] [Related]
22. Measurement of carbon monoxide transfer and lung volume in ventilated subjects. Macnaughton PD, Morgan CJ, Denison DM, Evans TW. Eur Respir J; 1993 Feb; 6(2):231-6. PubMed ID: 8444295 [Abstract] [Full Text] [Related]
26. Single-breath pulmonary diffusing capacity. Reference values and application in connective tissue diseases and in various lung diseases. Salorinne Y. Scand J Respir Dis Suppl; 1976 Jul; 96():1-84. PubMed ID: 1076826 [Abstract] [Full Text] [Related]
27. Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis. Tashkin DP, Volkmann ER, Tseng CH, Kim HJ, Goldin J, Clements P, Furst D, Khanna D, Kleerup E, Roth MD, Elashoff R. Ann Rheum Dis; 2016 Feb; 75(2):374-81. PubMed ID: 25452309 [Abstract] [Full Text] [Related]
33. [Disorders of pulmonary gas diffusion in liver cirrhosis]. Tulafić C, Perisic M, Rebić P. Srp Arh Celok Lek; 2002 Jul; 130(3-4):68-72. PubMed ID: 12154517 [Abstract] [Full Text] [Related]
34. Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis. Guarnieri G, Zanatta E, Mason P, Scarpa MC, Pigatto E, Maestrelli P, Cozzi F. Clin Exp Rheumatol; 2015 Jul; 33(4 Suppl 91):S80-6. PubMed ID: 25897784 [Abstract] [Full Text] [Related]
35. Evolution of changes in carbon monoxide transfer factor in men with chronic obstructive pulmonary disease. Osmanliev DP, Joyce H, Watson RA, Pride NB. Respir Med; 2005 Aug; 99(8):1053-60. PubMed ID: 15950148 [Abstract] [Full Text] [Related]
36. Comparison of four methods for calculating diffusing capacity by the single breath method. Beck KC, Offord KP, Scanlon PD. Chest; 1994 Feb; 105(2):594-600. PubMed ID: 8306770 [Abstract] [Full Text] [Related]
37. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease. Benyamine A, Heim X, Resseguier N, Bertin D, Gomez C, Ebbo M, Harlé JR, Kaplanski G, Rossi P, Bardin N, Granel B. Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320 [Abstract] [Full Text] [Related]
38. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. Garin MC, Highland KB, Silver RM, Strange C. J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563 [Abstract] [Full Text] [Related]
39. Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy? Yamakawa H, Takemura T, Iwasawa T, Yamanaka Y, Ikeda S, Sekine A, Kitamura H, Baba T, Iso S, Okudela K, Kuwano K, Ogura T. BMC Pulm Med; 2018 Jan 30; 18(1):25. PubMed ID: 29382307 [Abstract] [Full Text] [Related]
40. Reduction of pulmonary capillary blood volume in patients with severe unexplained pulmonary hypertension. Borland C, Cox Y, Higenbottam T. Thorax; 1996 Aug 30; 51(8):855-6. PubMed ID: 8795679 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]